Fmoc-L-Glu-OBzl is a protected amino acid derivative, specifically the γ-benzyl ester of Fmoc-L-glutamic acid. It features two orthogonal protecting groups: the base-labile 9-fluorenylmethoxycarbonyl (Fmoc) group on the α-amino function and the acid-labile benzyl (Bzl) group on the γ-carboxylic acid side chain. This design is critical for its primary application in solid-phase peptide synthesis (SPPS) using the Fmoc strategy. This compound serves as a crucial building block for the controlled incorporation of glutamic acid residues into peptide chains. The benzyl protection on the γ-side chain prevents undesired side reactions during the elongation of the peptide backbone, allowing for the synthesis of peptides containing glutamic acid with a free α-carboxyl group or for the subsequent selective deprotection and functionalization of the side chain. It is extensively used in the research and development of therapeutic peptides, peptide hormones, and as a key intermediate in the preparation of complex peptide-based active pharmaceutical ingredients (APIs) and biochemical probes. The product is a white to off-white crystalline powder, typically stored at low temperatures (e.g., 2-8°C) to ensure stability. Handling requires standard laboratory safety precautions for fine chemical powders, including the use of personal protective equipment to avoid inhalation or skin contact.